argenx SE vs Abbvie Inc.
ARGX vs ABBV — side-by-side comparison from reported financials. ARGX leads 6, ABBV leads 5 of 11 comparable metrics.
argenx SE
ARGX · Healthcare
$825.03+0.78%Strong
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | ARGX | ABBV |
|---|---|---|
| Price | $825.03 | $276.43 |
| Market cap | $51.9B | $488B |
| Revenue (TTM) | $4.24B | $64.4B |
| Revenue growth | +116.2% | +1.8% |
| Net margin | 30.5% | 9.8% |
| Free cash flow | $970M | $18.2B |
| Net cash (debt) | $5.14B | ($56.2B) |
| 1-year price return | +2.5% | +19.8% |
| P/E | 20.1 | 77.4 |
| P/E vs own history (cheap-side %) | 92% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 22% | 96% |
| Altman Z-score | 21.86 | 2.33 |
| CV checks passed | 8 of 10 | 9 of 10 |
| Employees | 1,863 | 57,000 |
Full résumé-style profiles: ARGX CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.